2023 Q3 Form 10-Q Financial Statement
#000165731223000017 Filed on August 03, 2023
Income Statement
| Concept | 2023 Q3 | 2023 Q2 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| YoY Change | ||
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | ||
| YoY Change | ||
| Gross Profit Margin | ||
| Selling, General & Admin | $13.35M | $12.44M |
| YoY Change | 152.42% | 125.12% |
| % of Gross Profit | ||
| Research & Development | $2.958M | $1.120M |
| YoY Change | -69.93% | -92.52% |
| % of Gross Profit | ||
| Depreciation & Amortization | $155.0K | $157.0K |
| YoY Change | -1.27% | -4.85% |
| % of Gross Profit | ||
| Operating Expenses | $16.31M | $9.965M |
| YoY Change | 7.82% | -51.41% |
| Operating Profit | -$16.31M | -$9.965M |
| YoY Change | 7.82% | -51.41% |
| Interest Expense | $401.0K | $740.0K |
| YoY Change | 245.69% | 713.19% |
| % of Operating Profit | ||
| Other Income/Expense, Net | $1.668M | $1.468M |
| YoY Change | -466.59% | -47.96% |
| Pretax Income | -$14.64M | -$8.497M |
| YoY Change | -6.03% | -51.96% |
| Income Tax | $44.00K | $310.0K |
| % Of Pretax Income | ||
| Net Earnings | -$14.69M | -$8.807M |
| YoY Change | -6.14% | -50.43% |
| Net Earnings / Revenue | ||
| Basic Earnings Per Share | -$0.02 | -$0.01 |
| Diluted Earnings Per Share | -$0.02 | -$0.01 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 635.9M shares | 635.7M shares |
| Diluted Shares Outstanding | 638.2M shares | 634.5M shares |
Balance Sheet
| Concept | 2023 Q3 | 2023 Q2 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $257.4M | $270.7M |
| YoY Change | 11.08% | 142.78% |
| Cash & Equivalents | $257.4M | $270.7M |
| Short-Term Investments | ||
| Other Short-Term Assets | $6.319M | $6.060M |
| YoY Change | 105.36% | 174.71% |
| Inventory | ||
| Prepaid Expenses | $3.332M | $894.0K |
| Receivables | ||
| Other Receivables | ||
| Total Short-Term Assets | $276.5M | $287.8M |
| YoY Change | 6.99% | 107.62% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $10.00K | $11.00K |
| YoY Change | -87.65% | -87.91% |
| Goodwill | $545.0K | $545.0K |
| YoY Change | 0.18% | 0.0% |
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | $15.00M | $15.00M |
| YoY Change | 0.0% | 0.0% |
| Other Assets | ||
| YoY Change | ||
| Total Long-Term Assets | $15.94M | $16.10M |
| YoY Change | -2.89% | -0.78% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $276.5M | $287.8M |
| Total Long-Term Assets | $15.94M | $16.10M |
| Total Assets | $292.5M | $303.9M |
| YoY Change | 6.4% | 96.27% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $823.0K | $2.493M |
| YoY Change | -89.72% | -73.38% |
| Accrued Expenses | $7.397M | $7.467M |
| YoY Change | -67.81% | -73.89% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $9.012M | $10.95M |
| YoY Change | -71.95% | -71.83% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $19.91M | $19.86M |
| YoY Change | 298.1% | 297.14% |
| Other Long-Term Liabilities | $20.00K | $30.00K |
| YoY Change | -91.07% | -77.27% |
| Total Long-Term Liabilities | $19.93M | $19.89M |
| YoY Change | 278.87% | 288.95% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $9.012M | $10.95M |
| Total Long-Term Liabilities | $19.93M | $19.89M |
| Total Liabilities | $28.94M | $30.84M |
| YoY Change | -22.6% | -29.88% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$374.1M | -$359.1M |
| YoY Change | 16.04% | 17.09% |
| Common Stock | $41.75M | $41.75M |
| YoY Change | 6.73% | 29.74% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | $746.0K | $975.0K |
| YoY Change | 66.15% | 64.97% |
| Treasury Stock Shares | ||
| Shareholders Equity | $263.5M | $273.1M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $292.5M | $303.9M |
| YoY Change | 6.4% | 96.27% |
Cashflow Statement
| Concept | 2023 Q3 | 2023 Q2 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$14.69M | -$8.807M |
| YoY Change | -6.14% | -50.43% |
| Depreciation, Depletion And Amortization | $155.0K | $157.0K |
| YoY Change | -1.27% | -4.85% |
| Cash From Operating Activities | -$12.73M | -$21.31M |
| YoY Change | -29.67% | 9.19% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $0.00 | $0.00 |
| YoY Change | -100.0% | |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | ||
| YoY Change | ||
| Cash From Investing Activities | $0.00 | $0.00 |
| YoY Change | -100.0% | |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 48.00K | 124.0K |
| YoY Change | -99.97% | -118.0% |
| NET CHANGE | ||
| Cash From Operating Activities | -12.73M | -21.31M |
| Cash From Investing Activities | 0.000 | 0.000 |
| Cash From Financing Activities | 48.00K | 124.0K |
| Net Change In Cash | -12.68M | -21.19M |
| YoY Change | -110.43% | 4.7% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$12.73M | -$21.31M |
| Capital Expenditures | $0.00 | $0.00 |
| Free Cash Flow | -$12.73M | -$21.31M |
| YoY Change | -29.67% | 9.35% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.09 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.09 | ||
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
9364000 | usd | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
6801000 | usd | |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
314000 | usd | |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
634469423 | shares |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
634469423 | shares |
| CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
484777837 | shares |
| CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
484777837 | shares |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
483226039 | shares | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
483226039 | shares | |
| CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
148005000 | usd |
| CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24837000 | usd |
| CY2022Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
0 | usd |
| CY2022Q1 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
793000 | usd |
| CY2022Q1 | vrna |
Adjustments To Additional Paid In Capital Reclassification From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalReclassificationFromShareBasedCompensation
|
-118000 | usd |
| CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3747000 | usd |
| CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
126307000 | usd |
| CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-17766000 | usd |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-25550000 | usd | |
| us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
1672000 | usd | |
| us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-3256000 | usd | |
| us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
88000 | usd | |
| us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
44000 | usd | |
| us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
51000 | usd | |
| us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
63000 | usd | |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
328000 | usd | |
| us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-1605000 | usd | |
| us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
694000 | usd | |
| vrna |
Increase Decrease In Tax And Tax Credit Receivables Current
IncreaseDecreaseInTaxAndTaxCreditReceivablesCurrent
|
380000 | usd | |
| vrna |
Increase Decrease In Tax And Tax Credit Receivables Current
IncreaseDecreaseInTaxAndTaxCreditReceivablesCurrent
|
6461000 | usd | |
| us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
2016000 | usd | |
| us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
143000 | usd | |
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-417000 | usd | |
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-680000 | usd | |
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-6285000 | usd | |
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
6347000 | usd | |
| vrna |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-305000 | usd | |
| vrna |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-338000 | usd | |
| us-gaap |
Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
|
-939000 | usd | |
| us-gaap |
Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
|
164000 | usd | |
| us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-951000 | usd | |
| us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-113000 | usd | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-27093000 | usd | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-34029000 | usd | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | usd | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
29000 | usd | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-29000 | usd | |
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
56909000 | usd | |
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
67000 | usd | |
| us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
9996000 | usd | |
| us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
0 | usd | |
| us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
0 | usd | |
| us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
1482000 | usd | |
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1904000 | usd | |
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | usd | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
68809000 | usd | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-1415000 | usd | |
| us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1184000 | usd | |
| us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-1397000 | usd | |
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
42900000 | usd | |
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-36870000 | usd | |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
227827000 | usd |
| CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
148380000 | usd |
| CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
270727000 | usd |
| CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
111510000 | usd |
| us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1215000 | usd | |
| us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1000 | usd | |
| us-gaap |
Interest Paid Net
InterestPaidNet
|
685000 | usd | |
| us-gaap |
Interest Paid Net
InterestPaidNet
|
115000 | usd | |
| vrna |
Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
|
1 | subsidiary | |
| CY2023Q2 | vrna |
Payments For Application Fees
PaymentsForApplicationFees
|
3200000 | usd |
| CY2023Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-359100000 | usd |
| us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | segment | |
| us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | segment | |
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:110%">Use of estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The preparation of interim unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these unaudited condensed consolidated financial statements include, but are not limited to, the accrual and prepayment of research and development expenses and the fair value of share-based compensation. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known, and actual results could differ from the Company’s estimates.</span></div> | ||
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
627996000 | shares | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
627996000 | shares | |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
483226000 | shares | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
483226000 | shares | |
| CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | |
| CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
| CY2023Q2 | vrna |
Accrued Research And Development Fees Current
AccruedResearchAndDevelopmentFeesCurrent
|
3609000 | usd |
| CY2022Q4 | vrna |
Accrued Research And Development Fees Current
AccruedResearchAndDevelopmentFeesCurrent
|
12314000 | usd |
| CY2023Q2 | vrna |
Accrued Professional Fees Listing And General Corporate Costs Current
AccruedProfessionalFeesListingAndGeneralCorporateCostsCurrent
|
1377000 | usd |
| CY2022Q4 | vrna |
Accrued Professional Fees Listing And General Corporate Costs Current
AccruedProfessionalFeesListingAndGeneralCorporateCostsCurrent
|
1364000 | usd |
| CY2023Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2481000 | usd |
| CY2022Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
74000 | usd |
| CY2023Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
7467000 | usd |
| CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
13752000 | usd |
| CY2023Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
5074000 | usd |
| CY2022Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3053000 | usd |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
9364000 | usd | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
6801000 | usd | |
| CY2022Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | |
| CY2022Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | |
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | ||
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
19276496 | shares |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
1320000 | shares |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
240000 | shares |
| CY2023Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
1050192 | shares |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
19306304 | shares |
| CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2824000 | shares |
| CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
80000 | shares |
| CY2023Q2 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
120000 | shares |
| CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
21930304 | shares |
| CY2023Q2 | dei |
Entity Listing Depository Receipt Ratio
EntityListingDepositoryReceiptRatio
|
8 | |
| CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8807000 | usd |
| CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-17766000 | usd |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-25550000 | usd | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-42603000 | usd | |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
634469000 | shares |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
634469000 | shares |
| CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
484778000 | shares |
| CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
484778000 | shares |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
48500000 | shares | |
| CY2023Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
48500000 | shares |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
46200000 | shares | |
| CY2022Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
46200000 | shares |
| CY2023Q2 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
6900000 | usd |
| CY2022Q4 | us-gaap |
Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
|
1500000 | usd |
| CY2023Q2 | us-gaap |
Loss Contingency Loss In Period
LossContingencyLossInPeriod
|
2100000 | usd |
| CY2023Q2 | vrna |
Loss Contingency Accrual Reversal Of Research And Development Costs
LossContingencyAccrualReversalOfResearchAndDevelopmentCosts
|
6300000 | usd |
